Trial Details
COMPLETEDBasic Information
| Clinical ID | c1322 |
|---|---|
| Identifier | NCT02618187 |
| Trial Title | A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: SER-287|DRUG: Placebo|DRUG: Placebo Pre-Treat|DRUG: Vancomycin Pre-Treat |
Participant Information
| Sponsor | Seres Therapeutics, Inc. |
|---|---|
| City | Marlborough |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2016-01-13 |
|---|---|
| Primary Completion Date | 2017-12-06 |
| Completion Date | 2018-01-26 |